How Can The Pharma Industry Help The Homeless?

| March 23, 2018

article image
In January I published, “Can JPM And BTS Make A Bigger Difference?” This was part one of a four-part blog series on my experience of attending this year’s J.P. Morgan Healthcare (JPM) and Biotech Showcase (BTS) conferences in San Francisco. In this particular blog, I wrote about the dichotomy observed between “the haves” (i.e., conference attendees and presenters) and “the have nothings” (i.e., San Francisco’s homeless population). For the past 30+ years, the haves annually flock to San Francisco in January to provide updates on a wide variety of medical miracles being worked on at their companies. The have nothings are the homeless we all pass while walking on the streets to and from JPM, BTS, and the dozens of other events taking place simultaneously. A suggestion was made that perhaps the organizers of these events could do a coordinated collection toward helping the local community with tackling its burgeoning problem.

Spotlight

Charité

Universitätsmedizin Berlin sees itself as a toplevel European location for medical research and patient care. Originally established in 1710 as a quarantine hospital outside the gates of Berlin, the Charité is inseparably linked with innovative scientifi c, medical and nursing achievements as well as with the names of outstanding physicians, including the pathologist Rudolf Virchow, the surgeon Ferdinand Sauerbruch and the founder of modern bacteriology, Robert Koch.

OTHER ARTICLES

Top Specialty Pharmacy Therapy Areas

Article | March 16, 2020

Accelerated by advancements in cancer treatments and a growing emphasis on personalized and precision medicine, specialty pharmacy represents a rapidly growing sector within the healthcare industry. In fact, the market is projected to grow to $500 billion by the end of this year—up from $200 billion in total U.S. specialty drug spending in 2017. Industry growth of this magnitude creates challenges for those looking to understand and penetrate the market. It can be difficult, after all, to maintain updated information about high-priority drug therapy areas or facility affiliations in a market that’s constantly changing.

Read More

How pharma can continue engaging HCPs in a world gripped by COVID-19

Article | April 10, 2020

Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programmes for physicians, nurses, and other healthcare professionals. Both Medscape and Medscape Education are part of WebMD Health Corp., an Internet Brands company. Face-to-face interactions between pharma and physicians have essentially ceased overnight during the COVID-19 pandemic, but that doesn’t mean HCPs have stopped looking for new medical information.

Read More

Pricing of drugs – at what cost?

Article | February 27, 2020

We go into a doctor’s office and leave with a diagnosis and a prescription. Next we stop by the pharmacy. In Germany, if your insurance is not private, you mostly don’t even know the price of your drug because it’s paid for directly by your insurance. You only notice the 5-10 Euros copay. But how is a drug priced in Germany? And (how) does data play a role in helping pharma secure an attractive price point? Let’s fast forward directly to the launch of a new drug. At the time of launch, the pharmaceutical company has to present patient level evidence of the drug’s added value compared to existing comparative therapies. In the first year, however, the drug’s price can be defined freely by the company.

Read More

Enabling Active Pharma Ingredients for Batch Balancing and Integration to SAP EWM

Article | April 6, 2020

Batch and its Classification system are two most potent weapons used in Chemical, Pharma or Medical life science industry to record the potency of a batch or technically called as Active Pharma Ingredients(API). These material consist of one or more active ingredients, concentrates, carrier materials, or impurities, and so on. The potency of the active ingredients varies from batch to batch. The active ingredient is the substance of greatest interest in the bill of materials, the proportion of which may vary from batch to batch. Therefore, during creation of a process order, the system must be able to select and adjust the batches needed to obtain the required amount of active ingredient. Take an example of a drug hydroxychloroquine which is used as potent weapon to fight COVID-19. This drug is manufactured by using API, however, the Potency of this API material vary from batch to batch. To map this kind of requirement in SAP ERP, SAP calls it as Material Quantity Calculation.

Read More

Spotlight

Charité

Universitätsmedizin Berlin sees itself as a toplevel European location for medical research and patient care. Originally established in 1710 as a quarantine hospital outside the gates of Berlin, the Charité is inseparably linked with innovative scientifi c, medical and nursing achievements as well as with the names of outstanding physicians, including the pathologist Rudolf Virchow, the surgeon Ferdinand Sauerbruch and the founder of modern bacteriology, Robert Koch.

Events